Spesolimab use in generalised pustular psoriasis flares
- PMID: 39216967
- DOI: 10.1016/S0140-6736(24)01558-7
Spesolimab use in generalised pustular psoriasis flares
Comment in
-
Spesolimab use in generalised pustular psoriasis flares - Authors' reply.Lancet. 2024 Aug 31;404(10455):847-848. doi: 10.1016/S0140-6736(24)01557-5. Lancet. 2024. PMID: 39216969 No abstract available.
Comment on
-
Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial.Lancet. 2023 Oct 28;402(10412):1541-1551. doi: 10.1016/S0140-6736(23)01378-8. Epub 2023 Sep 19. Lancet. 2023. PMID: 37738999 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical